Reactivity patterns of monoclonal anti-D
Pattern* . | Anti-D tested, n† . | Partial D . | ||||
---|---|---|---|---|---|---|
1-9 . | 1-37 . | DNB‡ . | DII1-153 . | DNU‡ . | DIV type 3‡ . | |
1 | 1 | 1 | + | + | + | − |
1 | 2 | 2 | + | + | + | − |
2 | 3 | 2 | + | + | + | − |
2 | 4 | 1 | + | + | + | − |
3 | 5 | 3 | + | + | + | − |
4 | 6 | 1 | − | − | + | − |
5 | 7 | 2 | + | + | + | + |
5 | 10 | 4 | + | + | + | + |
5 | 11 | 1 | + | + | + | + |
6/7 | 12 | 4 | + | + | + | + |
6/7 | 13 | 6 | + | + | + | + |
6/7 | 15/16 | 8 | + | + | + | + |
4 | + | + | + | − | ||
6/7 | 17 | 8 | + | + | + | + |
6/7 | 18 | 6 | + | + | + | + |
1 | − | + | + | + | ||
6/7 | 20/21 | 3 | + | + | + | + |
1 | + | + | + | − | ||
8 | 22 | 2 | + | + | + | + |
9 | 23 | 3 | + | − | + | − |
2 | − | − | + | − | ||
2 | + | − | − | − | ||
N/A | 31 | 2 | − | + | + | − |
N/A | 32 | 1 | + | + | + | + |
N/A | 33 | 1 | + | + | + | + |
N/A | 34 | 1 | + | + | − | − |
N/A | 35 | 1 | + | + | + | − |
N/A | 36 | 3 | + | + | + | − |
1 | + | + | − | − | ||
N/A | 37 | 5 | + | + | + | + |
Pattern* . | Anti-D tested, n† . | Partial D . | ||||
---|---|---|---|---|---|---|
1-9 . | 1-37 . | DNB‡ . | DII1-153 . | DNU‡ . | DIV type 3‡ . | |
1 | 1 | 1 | + | + | + | − |
1 | 2 | 2 | + | + | + | − |
2 | 3 | 2 | + | + | + | − |
2 | 4 | 1 | + | + | + | − |
3 | 5 | 3 | + | + | + | − |
4 | 6 | 1 | − | − | + | − |
5 | 7 | 2 | + | + | + | + |
5 | 10 | 4 | + | + | + | + |
5 | 11 | 1 | + | + | + | + |
6/7 | 12 | 4 | + | + | + | + |
6/7 | 13 | 6 | + | + | + | + |
6/7 | 15/16 | 8 | + | + | + | + |
4 | + | + | + | − | ||
6/7 | 17 | 8 | + | + | + | + |
6/7 | 18 | 6 | + | + | + | + |
1 | − | + | + | + | ||
6/7 | 20/21 | 3 | + | + | + | + |
1 | + | + | + | − | ||
8 | 22 | 2 | + | + | + | + |
9 | 23 | 3 | + | − | + | − |
2 | − | − | + | − | ||
2 | + | − | − | − | ||
N/A | 31 | 2 | − | + | + | − |
N/A | 32 | 1 | + | + | + | + |
N/A | 33 | 1 | + | + | + | + |
N/A | 34 | 1 | + | + | − | − |
N/A | 35 | 1 | + | + | + | − |
N/A | 36 | 3 | + | + | + | − |
1 | + | + | − | − | ||
N/A | 37 | 5 | + | + | + | + |
N/A indicates not applicable; +, a normal or weak positive result; and −, a negative result.
Pattern is as described previously by Lomas et al24 (1-9) and Scott21 (1-37).
A complete listing of the antibodies was published previously13 (Table 2). The following antibodies failed to agglutinate DNB: LOR17-6C7 (epD6), P3F20 (epD18), HIRO-7, HIRO-8 (epD23), NAU6-1G6, and NOU (epD31). In addition, the reactivity of the following anti-Ds differed from that of the majority assigned to the respective epitope: D-90/7, SAL20-12D5, LHM50/2B, BIRMA-DG3 (epD15/16), as well as VOL-3F6 (epD20/21) did not agglutinate DIV type 3; LHM77/64, BIRMA-D6 (epD23), and NAU6-4D5 (epD36) did not agglutinate DNU.
The DNB pattern was established with samples RIR-2 and RIR-3 and the DNU pattern with red cells of the original DNU donor.14 The DIV type 3 data are a reevaluation of the original pattern using a CcDee DIV type 3 donor from our local population.
The results depicted for D category II were determined by Scott21 and are shown for comparison.